Loading component...
Andrew Page pancreas cancer fund

A grateful patient of Dr. Andrew Page created the Andrew Page Pancreas Cancer Fund. Her name was Nancy Lyle. She was diagnosed with pancreas cancer and formed a unique bond with Dr. Page and the pancreas cancer surgery team at Piedmont Healthcare. She recruited her friends and family to donate to the fund, and her only caveat was that the money be used to help patients like herself understand and manage pancreas cancer. Nancy underwent chemotherapy and surgery and enrolled in a trial after her cancer recurred.
Unfortunately, Nancy died of pancreas cancer, but she left a legacy with Dr. Page to create and sustain four pillars of what she felt would help patients now and in the future. Those four areas are:
- The Atlanta Pancreas Cancer Conference
- A patient-led ambassadorship program (which was posthumously named in her honor)
- An impetus to grow research-led initiatives with TGen
- Miscellaneous fund to help patients in need
Organizational chart

All funds donated to the APPCF go directly to one of these four primary initiatives. There is no “Dean’s Tax,” meaning that 100% of donations go toward these patient-centered initiatives. All funds are at the discretion of Dr. Page.
- Primary sponsors of each initiative and sub-project are listed in the smaller boxes.
- Piedmont Atlanta Healthcare employees are designated with (PAH).
- Green boxes are represented by independent organizations that have volunteered to work with the APPCF.
- Gray boxes are projects in development.
Loading component...
Loading component...
3. Research with TGen
The Purple Pansies are a patient-advocacy group dedicated to increasing awareness, improving detection, and funding research for pancreas cancer. They are a private group with growing relationships with Piedmont Healthcare in Atlanta and the Translational Genomics Research Institute (TGen) in Arizona. Similar to the APPCF, the Pansies support patient-centered initiatives and research. One of their greatest accomplishments has been fundraising for cutting-edge trials at TGen. They are currently interested in supporting trials and using the APPCF to formalize a relationship between Piedmont and TGen to provide access to TGen’s therapies at Piedmont.

